Novo Nordisk ( NVO 5.29%) stock ran up 3.5% through 10:05 a.m. ET Friday morning on some good news for it (and for Eli Lilly ) that's also probably bad news for Hims & Hers Health ( HIMS -17.80%).

The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...

More than 2.4 million cases of MadeGood Granola Bars have been recalled across the U.S. due to the possibility that they may ...

The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...

As of December 2024, Guardant held $840 million of cash and marketable securities. However, it burned through approximately $390 million in 2022, $345 million in 2023, and $275 million in 2024.

A Chicago-based food company has issued a voluntary recall for a range of snacks across 35 states. ZB Importing LLC issued ...

The FDA has declared an end to the shortage of Novo Nordisk’s blockbuster drug semaglutide, threatening the ability for ...

United Natural Trading Inc. issued a recall for Wegmans organic dry roasted salted almonds in January because they were ...

The Make America Healthy Again movement had a negative impact on pharmaceutical innovation and the corporations responsible for it.

President Donald J. Trump pushed for significant health care changes during his first month back in office, through executive ...

A shortage of Danish drugmaker Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, has been resolved, ...

Hims & Hers Health Inc. has acquired a California-based manufacturing facility to expand its range of peptide treatments, ...